Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics Buyers' Guide Photonics Handbook Photonics Dictionary Newsletters Bookstore
Latest News Latest Products Features All Things Photonics Podcast
Marketplace Supplier Search Product Search Career Center
Webinars Photonics Media Virtual Events Industry Events Calendar
White Papers Videos Contribute an Article Suggest a Webinar Submit a Press Release Subscribe Advertise Become a Member


Varian Inc.

Varian Inc. of Palo Alto, Calif., has acquired Fourier transform mass spectrometry technology through its purchase of IonSpec Corp. of Lake Forest, Calif. The technique is used in laboratories to discover the function and structural characterization of proteins and other biomolecules. The information provides scientists with fundamental knowledge of how cells work and how diseases evolve, leading to new diagnostic research and drug targets. The company expects the agreement to facilitate the expansion of its technology portfolio and to increase participation in the study of proteins, nucleic acids and drug metabolites.

Explore related content from Photonics Media




LATEST NEWS

Terms & Conditions Privacy Policy About Us Contact Us

©2024 Photonics Media